Ethnic and genetic determinants of omeprazole disposition and effect*
- 23 August 1996
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 60 (2) , 157-167
- https://doi.org/10.1016/s0009-9236(96)90131-9
Abstract
To compare the pharmacokinetics and dynamics of omeprazole in white and Chinese subjects.This double-blind two-stage study, performed in the clinical research center of a university hospital, evaluated 15 healthy nonsmoking men (eight white subjects and seven Chinese extensive metabolizers of mephenytoin). Blood samples were obtained over 24 hours after the eighth omeprazole dose (40 mg/day). Omeprazole, omeprazole sulfone, and hydroxyomeprazole pharmacokinetics were calculated from the respective plasma concentration-time curves. Twelve- and 24-hour integrated plasma gastriun (AUCgas12 and AUCgas24) were calculated from the respective plasma gastrin concentrations. A week before the initiation of omeprazole the activities of CYP2D6, CYP2C19, and CYP3A4 were determined by previously established methods.Omeprazole concentrations were significantly lower (mean area under the plasma concentration time curve extrapolated to infinity [AUCO-infinity] +/- SEM; 7.53 +/- 1.21 versus 12.80 +/- 2.13 mumol.hr.L-1, respectively; p < 0.05) and its oral clearance greater (319 +/- 60 versus 183 +/- 35 ml/min, respectively; p < 0.05) in the white subjects than in the Chinese subjects. Omeprazole and omeprazole sulfone AUCO-infinity values were well correlated with the S/R mephenytoin ratio (r = 0.82 and r = 0.84, respectively; p < 0.001) and with urinary 4'-hydroxymephenytoin (r = -0.58 [p < 0.03] and r = -0.52 [p < 0.02], respectively). Fasting gastrin, AUCgas12, and AUCgas24 were significantly greater in the Chinese subjects than in the white subjects (30.0 +/- 6.4 versus 14.4 +/- 1.2 pmol, respectively [p < 0.02]; 661 +/- 114 versus 334 +/- 38 pmol.hr.L-1, respectively [p < 0.002]; and 1414 +/- 228 versus 747 +/- 99 pmol.hr.L-1, respectively [p < 0.004]). In addition, the S/R mephenytoin ratio and omeprazole AUCO-infinity correlated with the extent of omeprazole induced hypergastrinemia.The metabolism of omeprazole and the rise in gastrin concentration after its administration is genetically determined and ethnically dependent.Keywords
This publication has 37 references indexed in Scilit:
- Appropriate acid suppression in the treatment of acid-related conditionsPharmacology & Therapeutics, 1994
- Interethnic Differences in Omeprazole Metabolism in the Two S-Mephenytoin Hydroxylation Phenotypes Studied in Caucasians and OrientalsTherapeutic Drug Monitoring, 1994
- Variability in individual response to various doses of omeprazoleDigestive Diseases and Sciences, 1994
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsPharmacogenetics, 1992
- Interethnic variation of drug metabolismTrends in Pharmacological Sciences, 1991
- Ethnic Differences in Drug Disposition and ResponsivenessClinical Pharmacokinetics, 1991
- OmeprazoleNew England Journal of Medicine, 1991
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- Production and Evaluation of Antibodies for the Radioimmunoassay of GastrinScandinavian Journal of Clinical and Laboratory Investigation, 1972